Equibles does not estimate personal net worth.
Get an email with a short summary when West Pharmaceutical Services Inc publishes a filing, an earnings call transcript or a press release.
Get WST alertsEric Green is recorded as CEO at West Pharmaceutical Services Inc (WST). Eric Green has spoken on 22 earnings calls and 1 other investor event across 1 company, most recently for West Pharmaceutical Services Inc on July 23, 2026. West Pharmaceutical Services Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at West Pharmaceutical Services Inc includes Michel Lagarde (CEO and Board Member), Robert F. Friel (Chairman and Board Member), Kimberly Banks MacKay (General Counsel) and 7 others.
“I am pleased to report strong second quarter results, which exceeded our expectations on the top and bottom line. Revenues of $872 million were up 13% organically, and adjusted EPS of $2.37 was up 29% as compared to prior year.”
“As usual, if you've got questions, feel free to raise your hand and we'll incorporate you in. um you know standard opening question but we're going to pivot a little bit just given the aka last night on the cyber security issue um kind of have to lead off with that just curious what's your response to that and sort of…”
“I am pleased to report the year is off to a strong start with outstanding performance in the first quarter revenues and adjusted EPS, with both metrics coming in well above our expectations.”
“I'm pleased to report we delivered another solid quarter with fourth quarter revenues, adjusted EPS, and cash flow coming in above our expectations. Before I get into the details of the quarter, I would like to take a moment to reflect on what we accomplished in 2025.”
“I'm pleased to report we delivered solid third quarter results with revenues, margins, and adjusted EPS coming in above our expectations. Revenues of $805 million were up 5% on an organic basis.”
Medical Instruments & Supplies · Healthcare
CEO
